ALCAM/CD166 Protein, Human (HEK293, His)

Customer Review

Based on 1 Customer Validation

The ALCAM/CD166 protein is a cell adhesion molecule that mediates heterotypic and homotypic cell-to-cell contacts, promoting T cell activation, immune synapse formation, and LILRB4-mediated inhibition of T cell proliferation. ALCAM/CD166 Protein, Human (HEK293, His) is the recombinant human-derived ALCAM/CD166 protein, expressed by HEK293, with C-His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The ALCAM/CD166 protein is a cell adhesion molecule that mediates heterotypic and homotypic cell-to-cell contacts, promoting T cell activation, immune synapse formation, and LILRB4-mediated inhibition of T cell proliferation. ALCAM/CD166 Protein, Human (HEK293, His) is the recombinant human-derived ALCAM/CD166 protein, expressed by HEK293, with C-His labeled tag.

Background

ALCAM/CD166 protein serves as a pivotal cell adhesion molecule, orchestrating a spectrum of cellular interactions. It mediates both heterotypic cell-cell contacts through its interaction with CD6 and homotypic cell-cell contacts, promoting T-cell activation and proliferation. ALCAM contributes significantly to the formation and maturation of the immunological synapse by engaging with CD6. Additionally, it facilitates homotypic interactions with cells expressing ALCAM. Acting as a ligand for the LILRB4 receptor, ALCAM enhances LILRB4-mediated inhibition of T cell proliferation. The protein is indispensable for normal hematopoietic stem cell engraftment in the bone marrow and mediates the attachment of dendritic cells onto endothelial cells through homotypic interactions. ALCAM plays a vital role in inhibiting endothelial cell migration while promoting endothelial tube formation. It is crucial for the organization of the lymph vessel network and hematopoiesis, ensuring normal numbers of hematopoietic stem cells in the bone marrow. ALCAM's diverse functions extend to promoting in vitro osteoblast proliferation and differentiation, as well as influencing neurite extension, axon growth, and axon guidance. Notably, it inhibits membrane-bound isoforms by competing for the same interaction partners, restricts cell attachment via homotypic interactions, and simultaneously promotes endothelial cell migration while inhibiting endothelial cell tube formation.

Verified Bioactivity

Immobilized Human ALCAM, His Tag at 2 μg/mL(100 μL/Well) on the plate. Dose response curve for Anti-ALCAM Antibody, hFc Tag with the EC50 of 0.1-0.5 μg/mL determined by ELISA.

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • ALCAM (W28-A526)
      Accession # Q13740
    • His
    • C-term
  • Protein Length

    Extracellular Domain

  • Synonyms

    ALCAM; CD166 Antigen; Activated Leukocyte Cell Adhesion Molecule; CD166; MEMD; Activated Leucocyte Cell Adhesion Molecule

  • AA Sequence

    WYTVNSAYGDTIIIPCRLDVPQNLMFGKWKYEKPDGSPVFIAFRSSTKKSVQYDDVPEYKDRLNLSENYTLSISNARISDEKRFVCMLVTEDNVFEAPTIVKVFKQPSKPEIVSKALFLETEQLKKLGDCISEDSYPDGNITWYRNGKVLHPLEGAVVIIFKKEMDPVTQLYTMTSTLEYKTTKADIQMPFTCSVTYYGPSGQKTIHSEQAVFDIYYPTEQVTIQVLPPKNAIKEGDNITLKCLGNGNPPPEEFLFYLPGQPEGIRSSNTYTLTDVRRNATGDYKCSLIDKKSMIASTAITVHYLDLSLNPSGEVTRQIGDALPVSCTISASRNATVVWMKDNIRLRSSPSFSSLHYQDAGNYVCETALQEVEGLKKRESLTLIVEGKPQIKMTKKTDPSGLSKTIICHVEGFPKPAIQWTITGSGSVINQTEESPYINGRYYSKIIISPEENVTLTCTAENQLERTVNSLNVSAISIPEHDEADEISDENREKVNDQA

  • Predicted Molecular Mass

    57 kDa

  • Molecular Weight

    Approximately 60-80 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.

  • Glycosylation

    Yes

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

Lyophilized from 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00